When experts discuss hair loss in women, most point to the typical symptoms and causes. For instance, breakage and thinning ...

Why are we all so scared of it? I’m led to believe that Black women and femmes with alopecia aren’t the only ones affected by the disability. Maybe all Black women, especially those of us who ...

Alopecia areata. This is an autoimmune disease that ... It’s a common cause of hair thinning in women. Telogen effluvium forces your hair into the telogen phase, the final phase of your hair ...

Alopecia areata is more prevalent in Hispanic, Asian/Pacific Islander, and Black children than in non-Hispanic White children ...

Why are we all so scared of it? I’m led to believe that Black women and femmes with alopecia aren't the only ones affected by the disability. Maybe all Black women, especially those of us who ...

Alopecia Areata Awareness Month takes place every September with campaigners working to increase awareness, reduce stigma and empower those living with hair loss. Female hair loss is surprisingly ...

Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

Hair loss is a common issue as the body ages, but it rarely results in the loss of tufts of hair unless there is an underlying issue. There are times when hair-care habits can lead to scarring of the ...

The third condition is alopecia areata which is an autoimmune disease. It’s where “the immune system mistakenly attacks the hair follicles, leading to sudden hair loss in small, round patches on the ...

a hereditary and progressive condition known as male or female pattern hair loss, genetics aren’t the only risk factor: alopecia areata is a form of hair loss that appears as patchy bald spots ...

Alopecia areata is a disorder in which the body reacts against itself, an 'auto immune disorder', causing patches of hair to fall out. It can start at any age but is most likely to start in childhood.

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...